biotech · Glanzmann Thrombasthenia · Von Willebrand Disease (VWD) · COAG
Hemab Therapeutics Holdings
Hemab Therapeutics Holdings drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
frederiksberg, DK HQ
2020 Founded
90 Employees
Public company Type
COAG · NYSE Ticker
Company details
- Status
- Public
- HQ
- frederiksberg, DK
- Founded
- 2020
- Employees
- 90
- Programs
- 4
- Drugs
- 0
- Patents
- 0
Hemab Therapeutics Holdings pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Hemab Therapeutics Holdings drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.